Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.

Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 5

Abstract

Multiple sclerosis (MS) is a neurological disease of the central nervous system in which dissipated demyelination lesions develop. The currently available pharmacotherapy and rehabilitation for this disease aims to preserve the patients' physical abilities and prevent disease progression and nervous system damage. The study evaluated the direct and indirect costs associated with two different treatment regimens for multiple sclerosis diagnosed patients by comparing two groups of 60 subjects (Group A - patients receiving continuous interferon therapy (Betaferon) and steroids during relapses, and Group B - patients receiving steroid-only (Solu-Medrol, Metypred) treatment). The study was conducted over two years (2004-2005). The pharmacotherapy costs for MS patients were: PLN 4,555,360.68 (1,171,043.88euro) total for Group A and PLN 75,922.68 (19,517.40euro) per patient, and PLN 72,582.00 (18,658.61euro) total for Group B and PLN 1,209.70 (310.98euro) per patient. Total direct and indirect costs for Group A and Group B amounted to PLN 5,595,968.58 (1,438,552.33euro) and PLN 1,655,658.30 (425,619.10euro), respectively.

Authors and Affiliations

Arleta Matschay, Elzbieta Nowakowska, Hanka Hertmanowska, Krzysztof Kus, Anna Czubak

Keywords

Related Articles

Betulin, betulinic acid and butein are inhibitors of acetaldehyde-induced activation of liver stellate cells.

Liver fibrosis has been reported to be inhibited in vivo by oleanolic and ursolic acids; however, the activity of other triterpenes like betulin and betulinic acid has not been examined. Butein has also been reported to...

Association between remote organ injury and tissue polyamine homeostasis in acute experimental pancreatitis - treatment with a polyamine analogue bismethylspermine.

Experimental pancreatitis is associated with activation of polyamine catabolism. The polyamine analog bismethylspermine (Me(2)Spm) can ameliorate pancreatic injury. We investigated the roles of polyamine catabolism in re...

Residual fraction of the area under the curve as a qualitative criterion in pharmacokinetic studies.

The aim of the present study was to determine whether the residual area under the curve (AUC(res%); expressed as % of total value of AUC) could be used as a parameter for the qualitative evaluation of pharmacokinetic stu...

Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.

The therapeutic usefulness of doxorubicin (DXR), an anthracycline antibiotic, is limited by its cardiotoxicity. The present study investigated the effects of telmisartan, an angiotensin II receptor (AT1) antagonist again...

Nitric oxide effect on 5-hydroxytryptamine-induced vasoconstrictions of isolated smooth muscle.

The aim of the present study was to investigate a nitric oxide (NO) involvement in the mediation of a 5-HT-induced vasoconstriction response in the rat portal vein in vitro. Isolated rat portal vein segments were placed...

Download PDF file
  • EP ID EP134071
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Arleta Matschay, Elzbieta Nowakowska, Hanka Hertmanowska, Krzysztof Kus, Anna Czubak (2008). Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.. Pharmacological Reports, 60(5), 632-644. https://europub.co.uk/articles/-A-134071